Venous resection at pancreaticoduodenectomy can be safely performed in the presence of jaundice

作     者：Rupaly Pande James Hodson Ravi Marudanayagam Darius Mirza John Isaac Keith J Roberts Rupaly Pande;James Hodson;Ravi Marudanayagam;Darius Mirza;John Isaac;Keith J Roberts

作者机构：HPB SurgeryUniversity Hospitals Birmingham NHS Foundation TrustBirmingham B152THUK Institute of Translational MedicineUniversity Hospitals Birmingham NHS Foundation TrustBirmingham B152THUK Institute of Immunology and ImmunotherapyUniversity of BirminghamBirmingham B152THUK 

出 版 物：《Hepatobiliary & Pancreatic Diseases International》 (国际肝胆胰疾病杂志（英文版）)

年 卷 期：2020年第19卷第5期

页      面：488-491页

核心收录：

学科分类：1002[医学-临床医学] 100210[医学-外科学(含：普外、骨外、泌尿外、胸心外、神外、整形、烧伤、野战外)] 10[医学] 

基　　金：Pancreatic Cancer UK [CPA2015_05_BIRMINGHAM] Funding Source: Medline 

主　　题：jaundice resection routine 

摘      要：Venous resection at pancreaticoduodenectomy(PD)has established itself as a viable treatment for borderline resectable cancer,with equivalent survival to those patients undergoing PD for cancer without venous resection[1].Thus surgery for these patients is clearly desirable,when possible,compared to palliative ***,there is concern and debate about the safety of venous resection at PD[2].There is a need to improve patient pathways,outcome and experience[3].To this end,in patients who present with jaundice,it is clear that surgery without preoperative biliary drainage(PBD)reduces complications[4].In 2015,our team introduced a‘fast track’program to routinely perform PD in the presence of jaundice[5].This change of practice has become routine,with most patients now undergoing surgery without *** is,however,unclear whether portal vein(PV)resection+PD is safe in the setting of *** aim of this study,therefore,was to compare outcomes and complications between patients with or without jaundice undergoing PD with associated resection of the superior mesenteric vein(SMV)and/or PV.